Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Carcinoma, Oat Cell

idarubicin has been researched along with Carcinoma, Oat Cell in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Siegenthaler, P; VanHelvoirt, A1
Binaschi, M; Capranico, G; De Isabella, P; Pilotti, S; Pratesi, G; Supino, R; Zunino, F1
Benfield, GF; Cullen, MH; Smith, SR; Woodroffe, CM1
de Vries, EG; Le, TK; Meijer, C; Mulder, NH; Timmer-Bosscha, H; Zijlstra, JG1
Banham, SW; Cummings, J; Kaye, SB; Milroy, R2

Trials

1 trial(s) available for idarubicin and Carcinoma, Oat Cell

ArticleYear
Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:1

    Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Lung Neoplasms; Male; Middle Aged; Pilot Projects

1987

Other Studies

5 other study(ies) available for idarubicin and Carcinoma, Oat Cell

ArticleYear
Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Digestive System; Drug Evaluation; Heart; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Middle Aged

1984
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts.
    International journal of cancer, 1990, Oct-15, Volume: 46, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Southern; Carcinoma, Small Cell; Cell Line; Cell Transformation, Neoplastic; DNA Topoisomerases, Type II; DNA, Single-Stranded; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Idarubicin; Lung Neoplasms; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Proteins

1990
Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Lung Neoplasms; Middle Aged; Neoplasm Metastasis

1987
Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxo
    European journal of respiratory diseases. Supplement, 1987, Volume: 149

    Topics: Antibiotics, Antineoplastic; Carcinoma, Small Cell; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Idarubicin; Lung Neoplasms; Mitoxantrone; Naphthacenes; Tumor Stem Cell Assay

1987
Method for the determination of 4-demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatography.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4

    Topics: Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Hydroquinones; Idarubicin; Lung Neoplasms; Quinones

1987